Does OMALIZUMAB Cause Pulmonary hypertension? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Pulmonary hypertension have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.1% of all adverse event reports for OMALIZUMAB.
39
Reports of Pulmonary hypertension with OMALIZUMAB
0.1%
of all OMALIZUMAB reports
0
Deaths
17
Hospitalizations
How Dangerous Is Pulmonary hypertension From OMALIZUMAB?
Of the 39 reports, 17 (43.6%) required hospitalization, and 3 (7.7%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
Yes, Pulmonary hypertension is listed as a known adverse reaction in the official FDA drug label for OMALIZUMAB.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
Which OMALIZUMAB Alternatives Have Lower Pulmonary hypertension Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS